Monthly Archives: July 2013
How to: Juggle Multiple Brands Without Cannibalizing an Established Brand
Managing multiple brands at the same time requires excellent leadership and balancing skills. Bio-pharmaceutical companies today are developing and learning how to juggle multiple brands, without harming the market traction of previous products. Benchmark partners in a Best Practices, LLC
How to: Attract & Retain Engineering Talent in an Increasingly Competitive Labor Market
In order for companies to continue growing, and to distinguish themselves from competitors, it is essential to maintain top engineering talent. Despite this, leaders have often struggled with recruiting and retaining employees with high technology proficiency. With engineering talent a
What is Innovation? : Promoting & Enabling Innovation in Customer Marketing
Recently, bio-pharmaceutical leaders have been faced with various challenges that have forced them to become savvier, especially in the area of marketing innovations. In current news, Myriad Genetics, a molecular diagnostic company, is suing two competitors for offering similar genetic
Flying High on the Winds of Change: Embracing New Data Disclosure Requirements in Pharma Industry
A recent New York Times Article, “Drug Companies Promise More Data Transparency” discusses upcoming industry changes in the amount of data that Pharmaceutical companies will be releasing. Beginning January 1st, 2014, all new drugs and updates to existing drugs will
Capturing Valuable Insights: Internal vs. External Market Research
In recent years, organizations across all industries have increasingly been leveraging employees for market research projects. These projects allow organizations to gain key business-related insights and ultimately drive greater workforce engagement. Although companies are increasingly leveraging this internal tactic, they
Building Bridges to Key Audiences: Educating the Marketplace for Successful Diabetes Product Launches
Educating, informing, and preparing the marketplace for new products are all key factors in achieving the ultimate product success desired by organizations. Through the use of Physician, Payer and Patient education, as well as preparing publications and communication strategies, leaders
Roll the Dice: Playing the Clinical Trial Lottery
Clinical Trials are key stepping stones in the drug development process. Companies spend billions of dollars on drug testing each year – and yet, for a surprising number of medicines, we still don’t know if they’re really safe or effective.
Physicians & Patients Anxiously Await Results from Cholesterol-Reducing Drug Development Footrace
The recent discovery of a rare gene mutation causing cholesterol levels not imagined previously has caused a three-way footrace between industry giants, Sanofi, Pfizer, and Amgen. The pharmaceutical companies are all in the process of developing drugs that mimic the
China’s Crackdown on GlaxoSmithKline Shows Importance of Pharmaceutical Risk Management
As pharmaceutical giant GlaxoSmithKline undergoes intense scrutiny from the Chinese government, the rest of the World, especially the healthcare industry, looks on and awaits the ultimate findings or fallout from the investigation of the company’s alleged inappropriate practices. The investigation
Brand Management Excellence: Designing Successful Brand Teams Key to Brand Success
In order to maximize the value of a brand, critical decisions must be made at the right time & by the right people. Strategic brand management, as well as the knowledge of the critical structure of these groups, is essential
Benchmarking Quality: Maneuvering the FDA Regulations Obstacle Course
The Quality function within Medical device & diagnostics companies is critical for ensuring that products meet the tough standards put in place at every stage of the product lifecycle. Although the tasks completed by executives are increasing in importance, the
Avoiding Risky Business: Developing Effective REMS Plans
Due to strict FDA regulations regarding the safety of products, companies are now required to develop and deploy effective Risk Evaluation & Mitigation Strategy (REMS) plans. The ultimate goal of these plans is to both protect the public and ensure